Heart risk study for kids with cancer pulled before it started
NCT ID NCT04036045
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 22 times
Summary
This study planned to look for early markers of heart damage in children (ages 9 and older) newly diagnosed with cancer and receiving a type of chemotherapy called anthracyclines. Researchers wanted to use heart scans and blood tests to find which kids were most at risk. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Olga Salazar
Hartford, Connecticut, 06106, United States
Conditions
Explore the condition pages connected to this study.